Your browser doesn't support javascript.
loading
Anti-tumour immunity induces aberrant peptide presentation in melanoma.
Bartok, Osnat; Pataskar, Abhijeet; Nagel, Remco; Laos, Maarja; Goldfarb, Eden; Hayoun, Deborah; Levy, Ronen; Körner, Pierre-Rene; Kreuger, Inger Z M; Champagne, Julien; Zaal, Esther A; Bleijerveld, Onno B; Huang, Xinyao; Kenski, Juliana; Wargo, Jennifer; Brandis, Alexander; Levin, Yishai; Mizrahi, Orel; Alon, Michal; Lebon, Sacha; Yang, Weiwen; Nielsen, Morten M; Stern-Ginossar, Noam; Altelaar, Maarten; Berkers, Celia R; Geiger, Tamar; Peeper, Daniel S; Olweus, Johanna; Samuels, Yardena; Agami, Reuven.
Affiliation
  • Bartok O; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Pataskar A; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nagel R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Laos M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Goldfarb E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hayoun D; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Levy R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Körner PR; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Kreuger IZM; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Champagne J; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Zaal EA; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bleijerveld OB; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.
  • Huang X; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Kenski J; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wargo J; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Brandis A; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Levin Y; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mizrahi O; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alon M; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Lebon S; The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
  • Yang W; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Nielsen MM; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Stern-Ginossar N; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Altelaar M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Berkers CR; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Geiger T; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Peeper DS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Olweus J; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Samuels Y; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.
  • Agami R; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nature ; 590(7845): 332-337, 2021 02.
Article in En | MEDLINE | ID: mdl-33328638
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Protein Biosynthesis / T-Lymphocytes / Frameshift Mutation / Antigen Presentation / Melanoma Limits: Humans Language: En Journal: Nature Year: 2021 Document type: Article Affiliation country: Israel Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Protein Biosynthesis / T-Lymphocytes / Frameshift Mutation / Antigen Presentation / Melanoma Limits: Humans Language: En Journal: Nature Year: 2021 Document type: Article Affiliation country: Israel Country of publication: United kingdom